Company Performance - Inspire Medical Systems reported quarterly earnings of 0.10pershare,exceedingtheZacksConsensusEstimateofalossof0.23 per share, and improved from a loss of 0.34pershareayearago[1][2]−Theearningssurpriseforthisquarterwas143.481.15 per share against an expectation of 0.74,resultinginasurpriseof55.41201.32 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.20% and increasing from 164.01millionyear−over−year[3]MarketOutlook−Despitethepositiveearningsreport,Inspireshareshavedeclinedapproximately13.80.41 on revenues of 228.98million,andforthecurrentfiscalyear,itis2.16 on revenues of $949.61 million [8] Industry Context - Inspire operates within the Zacks Medical Info Systems industry, which is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable industry outlook [9] - The correlation between near-term stock movements and earnings estimate revisions suggests that tracking these revisions can provide insights into stock performance [6][7]